Figure 2.
Occurrence of P-loop mutations and T315I changes inversely with increasing nilotinib concentrations. The relative abundance of different mutations is depicted for each nilotinib concentration that was used in the screen. P-loop mutations included Q252H, Y253H, E255K, and E255V. A Q252H/S349L double mutant is shown separately.